To identify variants in SLC38A6, WGS was conducted on the remaining 1 412 ET patients in this study, including 772 familial ET probands (family history: similar manifestations in immediate family members or siblings) and 640 sporadic cases (family history: no similar manifestations in immediate family members or siblings). This evidence concerns the gene SLC38A6 and essential thrombocythemia.